<?xml version='1.0' encoding='utf-8'?>
<document id="26671563"><sentence text="Halofuginone Synergistically Enhances Anti-Proliferation of Rapamycin in T Cells and Reduces Cytotoxicity of Cyclosporine in Cultured Renal Tubular Epithelial Cells."><entity charOffset="0-12" id="DDI-PubMed.26671563.s1.e0" text="Halofuginone" /><entity charOffset="60-69" id="DDI-PubMed.26671563.s1.e1" text="Rapamycin" /><entity charOffset="109-121" id="DDI-PubMed.26671563.s1.e2" text="Cyclosporine" /><pair ddi="false" e1="DDI-PubMed.26671563.s1.e0" e2="DDI-PubMed.26671563.s1.e0" /><pair ddi="false" e1="DDI-PubMed.26671563.s1.e0" e2="DDI-PubMed.26671563.s1.e1" /><pair ddi="false" e1="DDI-PubMed.26671563.s1.e0" e2="DDI-PubMed.26671563.s1.e2" /><pair ddi="false" e1="DDI-PubMed.26671563.s1.e1" e2="DDI-PubMed.26671563.s1.e1" /><pair ddi="false" e1="DDI-PubMed.26671563.s1.e1" e2="DDI-PubMed.26671563.s1.e2" /></sentence><sentence text="Both rapamycin (RAPA) and cyclosporin A (CsA) are commonly used for immunosuppression, however their adverse side effects limit their application"><entity charOffset="5-14" id="DDI-PubMed.26671563.s2.e0" text="rapamycin" /><entity charOffset="16-20" id="DDI-PubMed.26671563.s2.e1" text="RAPA" /><entity charOffset="26-39" id="DDI-PubMed.26671563.s2.e2" text="cyclosporin A" /><entity charOffset="41-44" id="DDI-PubMed.26671563.s2.e3" text="CsA" /><pair ddi="false" e1="DDI-PubMed.26671563.s2.e0" e2="DDI-PubMed.26671563.s2.e0" /><pair ddi="false" e1="DDI-PubMed.26671563.s2.e0" e2="DDI-PubMed.26671563.s2.e1" /><pair ddi="false" e1="DDI-PubMed.26671563.s2.e0" e2="DDI-PubMed.26671563.s2.e2" /><pair ddi="false" e1="DDI-PubMed.26671563.s2.e0" e2="DDI-PubMed.26671563.s2.e3" /><pair ddi="false" e1="DDI-PubMed.26671563.s2.e1" e2="DDI-PubMed.26671563.s2.e1" /><pair ddi="false" e1="DDI-PubMed.26671563.s2.e1" e2="DDI-PubMed.26671563.s2.e2" /><pair ddi="false" e1="DDI-PubMed.26671563.s2.e1" e2="DDI-PubMed.26671563.s2.e3" /><pair ddi="false" e1="DDI-PubMed.26671563.s2.e2" e2="DDI-PubMed.26671563.s2.e2" /><pair ddi="false" e1="DDI-PubMed.26671563.s2.e2" e2="DDI-PubMed.26671563.s2.e3" /></sentence><sentence text=" Thus, it is of interest to develop novel means to enhance or preserve the immunosuppressive activity of RAPA or CsA while reducing their toxicity"><entity charOffset="105-107" id="DDI-PubMed.26671563.s3.e0" text="RAPA" /><entity charOffset="113-115" id="DDI-PubMed.26671563.s3.e1" text="CsA" /><pair ddi="false" e1="DDI-PubMed.26671563.s3.e0" e2="DDI-PubMed.26671563.s3.e0" /><pair ddi="false" e1="DDI-PubMed.26671563.s3.e0" e2="DDI-PubMed.26671563.s3.e1" /></sentence><sentence text=" Halofuginone (HF) has been recently tested as a potential immunosuppressant"><entity charOffset="1-13" id="DDI-PubMed.26671563.s4.e0" text="Halofuginone" /><entity charOffset="15-17" id="DDI-PubMed.26671563.s4.e1" text="HF" /><pair ddi="false" e1="DDI-PubMed.26671563.s4.e0" e2="DDI-PubMed.26671563.s4.e0" /><pair ddi="false" e1="DDI-PubMed.26671563.s4.e0" e2="DDI-PubMed.26671563.s4.e1" /></sentence><sentence text=" This study investigated the interaction of HF with RAPA or with CsA in cell cultures"><entity charOffset="52-53" id="DDI-PubMed.26671563.s5.e0" text="RAPA" /><entity charOffset="65-66" id="DDI-PubMed.26671563.s5.e1" text="CsA" /><entity charOffset="44-45" id="DDI-PubMed.26671563.s5.e2" text="HF" /><pair ddi="false" e1="DDI-PubMed.26671563.s5.e2" e2="DDI-PubMed.26671563.s5.e2" /><pair ddi="false" e1="DDI-PubMed.26671563.s5.e2" e2="DDI-PubMed.26671563.s5.e0" /><pair ddi="false" e1="DDI-PubMed.26671563.s5.e2" e2="DDI-PubMed.26671563.s5.e1" /><pair ddi="false" e1="DDI-PubMed.26671563.s5.e0" e2="DDI-PubMed.26671563.s5.e0" /><pair ddi="false" e1="DDI-PubMed.26671563.s5.e0" e2="DDI-PubMed.26671563.s5.e1" /></sentence><sentence text=" Cell proliferation in cultures was determined using methylthiazol tetrazolium assay, and cell apoptosis assessed by flow cytometric analysis and Western blot"><entity charOffset="53-78" id="DDI-PubMed.26671563.s6.e0" text="methylthiazol tetrazolium" /></sentence><sentence text=" The drug-drug interaction was determined according to Loewe's equation or Bliss independence" /><sentence text=" Here, we showed that addition of HF to anti-CD 3 antibody-stimulated splenocyte cultures induced synergistic suppression of T cell proliferation in the presence of RAPA, indicated by an interaction index (Î³) value of &lt; 1"><entity charOffset="165-189" id="DDI-PubMed.26671563.s8.e0" text="RAPA" /><entity charOffset="34-58" id="DDI-PubMed.26671563.s8.e1" text="HF" /><pair ddi="false" e1="DDI-PubMed.26671563.s8.e1" e2="DDI-PubMed.26671563.s8.e1" /><pair ddi="false" e1="DDI-PubMed.26671563.s8.e1" e2="DDI-PubMed.26671563.s8.e0" /></sentence><sentence text="0 between HF and RAPA, but not in those with CsA"><entity charOffset="17-18" id="DDI-PubMed.26671563.s9.e0" text="RAPA" /><entity charOffset="45-46" id="DDI-PubMed.26671563.s9.e1" text="CsA" /><entity charOffset="10-11" id="DDI-PubMed.26671563.s9.e2" text="HF" /><pair ddi="false" e1="DDI-PubMed.26671563.s9.e2" e2="DDI-PubMed.26671563.s9.e2" /><pair ddi="false" e1="DDI-PubMed.26671563.s9.e2" e2="DDI-PubMed.26671563.s9.e0" /><pair ddi="false" e1="DDI-PubMed.26671563.s9.e2" e2="DDI-PubMed.26671563.s9.e1" /><pair ddi="false" e1="DDI-PubMed.26671563.s9.e0" e2="DDI-PubMed.26671563.s9.e0" /><pair ddi="false" e1="DDI-PubMed.26671563.s9.e0" e2="DDI-PubMed.26671563.s9.e1" /></sentence><sentence text=" The synergistic interaction of RAPA with HF in the suppression of T cell proliferation was also seen in a mixed lymphocyte reaction and Jurkat T cell growth, and was positively correlated with an increase in cell apoptosis, but not with proline depletion"><entity charOffset="238-245" id="DDI-PubMed.26671563.s10.e0" text="proline" /><entity charOffset="32-38" id="DDI-PubMed.26671563.s10.e1" text="RAPA" /><entity charOffset="42-48" id="DDI-PubMed.26671563.s10.e2" text="HF" /><pair ddi="false" e1="DDI-PubMed.26671563.s10.e1" e2="DDI-PubMed.26671563.s10.e1" /><pair ddi="false" e1="DDI-PubMed.26671563.s10.e1" e2="DDI-PubMed.26671563.s10.e2" /><pair ddi="false" e1="DDI-PubMed.26671563.s10.e1" e2="DDI-PubMed.26671563.s10.e0" /><pair ddi="false" e1="DDI-PubMed.26671563.s10.e2" e2="DDI-PubMed.26671563.s10.e2" /><pair ddi="false" e1="DDI-PubMed.26671563.s10.e2" e2="DDI-PubMed.26671563.s10.e0" /></sentence><sentence text=" In cultured kidney tubular epithelial cells, HF attenuated the cytotoxicity of CsA"><entity charOffset="80-81" id="DDI-PubMed.26671563.s11.e0" text="CsA" /><entity charOffset="46-47" id="DDI-PubMed.26671563.s11.e1" text="HF" /><pair ddi="false" e1="DDI-PubMed.26671563.s11.e1" e2="DDI-PubMed.26671563.s11.e1" /><pair ddi="false" e1="DDI-PubMed.26671563.s11.e1" e2="DDI-PubMed.26671563.s11.e0" /></sentence><sentence text=" In conclusion, these data indicate that HF synergistically enhances anti-T cell proliferation of RAPA and reduces the nephrotoxicity of CsA in vitro, suggesting the potential use of HF for enhancing anti-T cell proliferation of RAPA and reducing CsA-mediated nephrotoxicity"><entity charOffset="98-99" id="DDI-PubMed.26671563.s12.e0" text="RAPA" /><entity charOffset="229-230" id="DDI-PubMed.26671563.s12.e1" text="RAPA" /><entity charOffset="137-138" id="DDI-PubMed.26671563.s12.e2" text="CsA" /><entity charOffset="247-248" id="DDI-PubMed.26671563.s12.e3" text="CsA" /><entity charOffset="41-42" id="DDI-PubMed.26671563.s12.e4" text="HF" /><entity charOffset="183-184" id="DDI-PubMed.26671563.s12.e5" text="HF" /><pair ddi="false" e1="DDI-PubMed.26671563.s12.e4" e2="DDI-PubMed.26671563.s12.e4" /><pair ddi="false" e1="DDI-PubMed.26671563.s12.e4" e2="DDI-PubMed.26671563.s12.e0" /><pair ddi="false" e1="DDI-PubMed.26671563.s12.e4" e2="DDI-PubMed.26671563.s12.e2" /><pair ddi="false" e1="DDI-PubMed.26671563.s12.e4" e2="DDI-PubMed.26671563.s12.e5" /><pair ddi="false" e1="DDI-PubMed.26671563.s12.e4" e2="DDI-PubMed.26671563.s12.e1" /><pair ddi="false" e1="DDI-PubMed.26671563.s12.e4" e2="DDI-PubMed.26671563.s12.e3" /><pair ddi="false" e1="DDI-PubMed.26671563.s12.e0" e2="DDI-PubMed.26671563.s12.e0" /><pair ddi="false" e1="DDI-PubMed.26671563.s12.e0" e2="DDI-PubMed.26671563.s12.e2" /><pair ddi="false" e1="DDI-PubMed.26671563.s12.e0" e2="DDI-PubMed.26671563.s12.e5" /><pair ddi="false" e1="DDI-PubMed.26671563.s12.e0" e2="DDI-PubMed.26671563.s12.e1" /><pair ddi="false" e1="DDI-PubMed.26671563.s12.e0" e2="DDI-PubMed.26671563.s12.e3" /><pair ddi="false" e1="DDI-PubMed.26671563.s12.e2" e2="DDI-PubMed.26671563.s12.e2" /><pair ddi="false" e1="DDI-PubMed.26671563.s12.e2" e2="DDI-PubMed.26671563.s12.e5" /><pair ddi="false" e1="DDI-PubMed.26671563.s12.e2" e2="DDI-PubMed.26671563.s12.e1" /><pair ddi="false" e1="DDI-PubMed.26671563.s12.e2" e2="DDI-PubMed.26671563.s12.e3" /><pair ddi="false" e1="DDI-PubMed.26671563.s12.e5" e2="DDI-PubMed.26671563.s12.e5" /><pair ddi="false" e1="DDI-PubMed.26671563.s12.e5" e2="DDI-PubMed.26671563.s12.e1" /><pair ddi="false" e1="DDI-PubMed.26671563.s12.e5" e2="DDI-PubMed.26671563.s12.e3" /><pair ddi="false" e1="DDI-PubMed.26671563.s12.e1" e2="DDI-PubMed.26671563.s12.e1" /><pair ddi="false" e1="DDI-PubMed.26671563.s12.e1" e2="DDI-PubMed.26671563.s12.e3" /></sentence><sentence text=" " /></document>